Kura Oncology (KURA) Upgraded by Zacks Investment Research to Hold

Kura Oncology} stock has undergone multiple analysts rating changes in the recent past.  Kura Oncology Upgraded by Zacks Investment Research on 10-12-21. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More Kura Oncology (KURA) Upgraded by Zacks Investment Research to Hold

How Have the Numbers Shaped Up for Kura Oncology (NASDAQ:KURA)

Earnings results for Kura Oncology , Analyst Opinion on Kura Oncology , Earnings and Valuation of (NASDAQ:KURA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More How Have the Numbers Shaped Up for Kura Oncology (NASDAQ:KURA)

Confused? Buy or Sell in volatile market – Analyst report Kura Oncology (NASDAQ:KURA)

Earnings results for Kura Oncology , Analyst Opinion on Kura Oncology , Earnings and Valuation of (NASDAQ:KURA), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Confused? Buy or Sell in volatile market – Analyst report Kura Oncology (NASDAQ:KURA)